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Introduction
Colorectal cancer is the second most common cause of cancer death in the United Kingdom and Europe. 1 Following potentially curative surgery, prognosis and the need for adjuvant therapy is primarily based on pathological assessment of the depth of invasion of the primary tumor and the presence of lymphatic and distant organ metastases. 2 However, this TNM-based staging may fail to accurately stage all patients, and in particular those with earlier stage, lymph node negative disease, where other tumor characteristics may identify patients at increased risk and who may benefit from adjuvant treatment.
In addition to such tumor-based characteristics, assessment of the tumor microenvironment may similarly inform prognosis. For example, it is now accepted that the host local inflammatory response is an important determinant of disease progression and oncological outcome in patients with colorectal cancer, with the presence of a conspicuous inflammatory cell infiltrate identified as an independent predictor of improved survival. 3, 4 Although semi-quantitative, histopathological assessment of the density of the generalised inflammatory cell infiltrate using routine pathological specimens has been validated as a stage-independent prognostic characteristic, 5, 6 the prognostic value of immunohistochemistry-based assessment of immune cell type and location within the tumor microenvironment, such as the Immunoscore, has been of interest. 7, 8 Although initially describing the density of cytotoxic (CD8 + ) and memory (CD45R0 + ) T-lymphocytes within the tumor microenvironment, the Immunoscore has recently been refined to reflect a cumulative score based on the density of the overall mature CD3 + T-lymphocyte population in addition to the CD8 + T-lymphocyte population within the tumor invasive margin and tumor core, and has been validated as a prognostic marker with superior prognostic ability compared to TNM staging in colorectal cancer. [8] [9] [10] However, whether the Immunoscore is superior to the Klintrup-Mäkinen (KM) assessment of the generalised inflammatory cell infiltrate remains to be determined.
Together with the inflammatory cell infiltrate, the tumor-associated stroma has also been characterised as an important determinant of disease progression in colorectal cancer.
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In particular, assessment of the proportion of stroma, or tumor stroma percentage (TSP), within the tumor microenvironment has been shown to predict survival independent of TNM stage for patients undergoing potentially curative resection of colorectal cancer as well as other cancers. [12] [13] [14] [15] [16] Furthermore, in patients with colorectal cancer, TSP has been shown to hold prognostic value independent of the inflammatory cell infiltrate as assessed using the KM grade. 13 Indeed, combined assessment of KM grade and TSP, termed the Glasgow Microenvironment Score (GMS), stratified survival greater than either measure alone, and in particular further stratified survival of those patients with a weak local inflammatory cell infiltrate. 17 However, whether inclusion of a potentially more detailed measure of the inflammatory cell infiltrate, such as the Immunoscore, may alter the prognostic value of the tumor-associated stroma is not clear. Therefore, the present study of patients undergoing potentially curative resection of stage I-III colorectal cancer has two aims: to compare the prognostic value of assessment of the inflammatory cell infiltrate using the KM grade and the Immunoscore, and to examine the clinical utility of combined assessment of the inflammatory cell infiltrate and TSP. The systemic inflammatory response, a stage-independent predictor of survival in patients with colorectal cancer, was reported using the modified Glasgow Prognostic Score (mGPS) as previously described. 18 Briefly, patients with serum C-reactive protein (CRP) ≤ 10mg/L were given a score of 0, patients with CRP> 10mg/L and serum albumin≥ 35g/L a score of 1, and patients with CRP> 10mg/L and albumin < 35g/L a score of 2. Serum CRP and albumin were recorded within 30 days prior to surgery for patients undergoing elective resection and on admission for patients undergoing emergency resection.
Patients and Methods

Patients and clinicopathological characteristics
Assessment of the tumor microenvironment
The generalised inflammatory cell infiltrate was assessed using the KM score as previously described. 6 Briefly, haematoxylin and eosin-stained ( Full sections of the invasive margin were stained using antibodies for CD3 + , a mature T-lymphocyte marker, and CD8 + , a marker of cytotoxic T-lymphocytes, as previously described. 19 The Immunoscore was then calculated as previously described. 8, 19 Briefly, the density of CD3 + and CD8 + T-cells within the invasive margin and tumor centre were separately semi-quantitatively graded as high or low; the Immunoscore was calculated from the number of regions with a high CD3 + and CD8 + cell density, giving five potential groups (Im0, Im1, Im2, Im3, Im4), ranging from all regions low density (Im0) to all regions high density (Im4).
Tumor stroma percentage was examined as previously described. 13 Briefly, using 
Survival
Following resection patients were routinely followed-up for five years according to local treatment and surveillance guidelines. Date and cause of death were crosschecked with the cancer registration system and the Registrar General (Scotland). Cancer-specific survival was measured in months as the date from surgery until date of death from recurrent or metastatic colorectal cancer. Death records were complete until March 31, 2014, which acted as the censor date.
Statistical analysis
The relationship between components of the tumor microenvironment and cancerspecific survival was examined using Kaplan-Meier log-rank analysis, with five-year survival presented as percentage surviving (standard error). The relationship between components of the tumor microenvironment, clinicopathological characteristic and survival was examined using multivariate Cox proportional hazards regression to calculate hazard ratios (HR) and 95% confidence intervals (CI). Variables with a P-value ≤0.05 on univariate regression analysis were entered into a multivariate model using a backward conditional approach. All statistical analyses were performed using SPSS version 22.0 (IBM SPSS). A P-value ≤0.05 was considered statistically significant.
Results
The study population was comprised of 246 patients undergoing potentially curative resection of stage I-III colorectal cancer. Clinicopathological characteristics are displayed in 
Relationship between local inflammatory cell infiltrate and cancer-specific survival
The relationship between the inflammatory cell infiltrate and cancer-specific survival is displayed in Figure 2 . The KM score was associated with cancer-specific survival (P=0.015; Figure 1a ). When classified as low grade or high grade, a low KM grade was associated with poorer five-year survival (66% vs. 88%; P=0.002; Figure 1b) . When stratified by tumor site (Supplementary Table 1 Table 2 ). The KM grade stratified five-year cancer-specific survival from 88% (high grade) to 66% and the Immunoscore stratified survival from 93% to 61%. The Immunoscore was able to further stratify the survival of patients with both a low and high KM grade; the survival of patients with a low grade KM ranged from 90% (Im4) to 60% (Im0/1) (P=0.015), whereas the survival of patients with a high grade KM ranged from 94% (Im4) to 71% (Im0/1) (P=0.010). In contrast, the KM grade did not further significantly stratify the Immunoscore.
Relationship between tumor stroma percentage, the tumor inflammatory cell infiltrate and cancer-specific survival
The prognostic value of combined assessment of the inflammatory cell infiltrate and TSP was subsequently examined (Table 3 ). The TSP significantly stratified the survival of patients from 80% (low TSP) to 57% (high TSP) (P=0.001). In combination with the inflammatory cell infiltrate, TSP significantly stratified survival of those with a weak infiltrate but not those with a strong infiltrate. In particular, TSP significantly stratified survival of patients with a low KM grade from 75% to 47% (P<0.001), whereas in patients with a high KM grade, survival of patients with a low TSP was comparable to that of patients with a high TSP (P=0.485). In combination with the Immunoscore, the effect of TSP on survival decreased as the Immunoscore increased; TSP stratified the survival of patients with Im0/1 from 71% to 38% (P<0.001) and patients with Im2/3 from 87% to 77% (P=0.069), but not patients with Im4 (P=0.545) (Figure 4) . Conversely, assessment of the inflammatory cell infiltrate was able to stratify survival of patients with both a high and low TSP; KM grade stratified patients with a low TSP from 88% to 75% (P=0.081) and patients with a high TSP from 87% to 47% (P=0.034), whereas Immunoscore stratified survival of patients with a low TSP from 92% to 71% (P=0.002) and patients with a high TSP from 100% to 38% (P=0.004).
Relationship between the tumor microenvironment, clinicopathological characteristics and cancer-specific survival
On univariate survival analysis ( 
Discussion
In the present study, an immunohistochemistry-based assessment of the inflammatory cell infiltrate was superior to that of H&E-based assessment in predicting outcome of patients undergoing potentially curative resection of stage I-III colorectal cancer. Furthermore, the combination of assessment of the inflammatory cell infiltrate, using either KM grade or
Immunoscore, and assessment of the tumor-associated stroma, using TSP, provided additional prognostic information.
The present study compared the prognostic utility of two validated measures of the tumor inflammatory cell infiltrate -the KM grade and the Immunoscore. 5, 8 Although both
were associated with cancer-specific survival, the Immunoscore, an immunohistochemistrybased assessment of CD3 + and CD8 + T-lymphocyte density, was able to better stratify survival of patients than the KM grade, an H&E-based assessment of the generalised inflammatory cell infiltrate. In particular, the Immunoscore was able to stratify survival of patients with both a low and high KM grade; indeed, survival of patients with a low KM grade but high Immunoscore was comparable to that of patients with a high KM grade.
The relative difference in the prognostic value of both measures of the inflammatory cell infiltrate may be explained by the components of the immune response that each measures. Whereas the KM grade provides a measure of the overall, generalised inflammatory cell infiltrate, the Immunoscore measures the host adaptive T-lymphocytic response to cancer. Indeed, although an increase in KM grade is associated with an increase in the density of tumor-infiltrating T-lymphocytes, [19] [20] [21] it is also associated with an increase in the density of the innate immune infiltrate, and in particular neutrophils and macrophages. 20, 21 For example, in the present study, within the group of patients with a high KM grade, the number of patients with a low (Im0/1, n=19) or high (Im4, n=21) Immunoscore was similar, whereas of those patients with a low KM grade, a small number had a high Immunoscore.
However, although the importance of host adaptive anti-tumor immune responses is recognised, it is now appreciated that myeloid-derived cells, such as neutrophils and macrophages, play an important functional role in promoting tumor progression. 22 Indeed, it remains to be determined whether immunohistochemical assessment of the innate immune infiltrate may increase the clinical and prognostic utility of measuring the inflammatory cell infiltrate in patients with colorectal cancer.
It was of interest in the present cohort that TSP, an assessment of the tumorassociated stroma, was associated with survival independent of either measure of the inflammatory cell infiltrate, and that combined assessment provided greater prognostic value.
For example, it was possible to stratify five-year survival from 92% (Im4, low TSP) to 38%
(Im0/1, high TSP). Furthermore, although the relationship between TSP and survival was strongest in patients with a poor inflammatory cell infiltrate, both the number of patients with a high TSP, and its prognostic value, decreased as the density of the inflammatory infiltrate increased. Although it has previously been suggested that the presence of a tumor-associated stroma precludes effective infiltration of the tumor microenvironment by an anti-tumor immune response, 23 the present results are consistent with our previous findings, 17 and may favour the alternative hypothesis that loss of the adaptive immune infiltrate predisposes to the development of a pro-tumor stromal compartment, potentially mediated by the residual innate immune infiltrate. 21, 24, 25 We have previously proposed a novel prognostic score based on assessment of the KM grade and TSP, termed the Glasgow Microenvironment Score, 17 however the present results suggest that a similar scheme may be applied to the combination of the Immunoscore and TSP and may have even greater clinical utility. Indeed, such a combination may optimise risk prediction in patients undergoing colorectal cancer resection by identifying both those with an excellent prognosis (Im4; five-year cancer-specific survival of 93%), and those with an extremely poor prognosis who may benefit from adjuvant therapy (Im0/1, high TSP; fiveyear cancer-specific survival of 38%).
In the present study, it was of interest that both the systemic inflammatory response as measured by mGPS, and the local inflammatory cell infiltrate as measured by KM grade or
Immunoscore had independent prognostic value in the multivariate analysis. It is likely that these measures reflect the same underlying process and therefore it would be of interest to compare the local and systemic inflammatory responses and how they may be combined to form a prognostic score. Indeed, Turner and colleagues have recently combined measures of the local and systemic inflammatory response to give better risk stratification in patients with node negative colorectal cancer 26 . However, the rationale of their approach that combined the neutrophil: lymphocyte ratio (NLR) and assessment of the chronic inflammatory cell density, was not clear since different cell types were assessed locally and systemically.
Indeed, only approximately 20% of patients had an elevated NLR and a low chronic inflammatory cell density, and therefore this score does not capture the same entity.
Similarly, combinations of other systemic and local inflammatory measures, such as the mGPS and KM grade or Immunoscore, will have such limitations. Moreover, the numbers of patients included in the present study (n=246) limits the value of such analysis and therefore was not formally examined.
Of note in the present study, the use of adjuvant chemotherapy was not associated with a significant improvement in survival and, in patients with node negative disease, showed a non-significant trend towards poorer survival. However, given the effect size of adjuvant chemotherapy in patients with node negative disease is modest (3.6% absolute improvement in survival of patients with stage II disease at five years in the QUASAR trial (n=2983)), 27 the present study did not have sufficient statistical power to examine the impact of adjuvant chemotherapy on survival of patients with colorectal cancer.
The present study is perhaps limited by its use of manual, semi-quantitative assessment of the inflammatory cell infiltrate as opposed to automated assessment as has been recommended for routine assessment of the Immunoscore. 8 However, the manual techniques employed showed excellent inter-operator agreement 6, 19 and manual assessment of the inflammatory cell infiltrate has been shown to correlate strongly with automated assessment. 28, 29 Furthermore, manual assessment of immunohistochemical staining may allow for greater discrimination of non-specific, background staining and provide superior prognostic value compared to automated assessment. 29 Furthermore, meaningful statistical analysis was precluded by the small number of patients in particular subgroups, such as those with stage II disease and high-risk pathological characteristics, or patients with stage I disease. Finally, the results of the present study, and in particular the prognostic utility of combined assessment of the inflammatory cell infiltrate and tumor-associated stroma, remain to be validated in an independent patient cohort from an independent centre.
In conclusion, the present results suggest that the prognostic value of an immunohistochemistry-based assessment of the inflammatory cell infiltrate is superior to H&E-based assessment in patients undergoing potentially curative resection of stage I-III colorectal cancer. Furthermore, TSP improves the prediction of survival by either measure of the inflammatory cell infiltrate. 
